作者：
Nicholas J,Short [1]
;
Agnieszka,Wierzbowska [2]
;
Thomas,Cluzeau [3]
;
Kamel,Laribi [4]
;
Christian,Recher [5]
;
Jaroslaw,Czyz [6]
;
Bogdan,Ochrem [7]
;
Lionel,Ades [8]
;
Maria Pilar,Gallego-Hernanz [9]
;
Mael,Heiblig [10]
;
Ernesta,Audisio [11]
;
Ewa,Zarzycka [12]
;
Shuli,Li [13]
;
Nicholas,Ferenc [13]
;
Tammie,Yeh [13]
;
Douglas V,Faller [13]
;
Farhad,Sedarati [13]
;
Cristina,Papayannidis [14]
作者单位：
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
[1]
Department of Hematology, Medical University of Lodz, Lodz, Poland.
[2]
Department of Hematology, Centre Hospitalier Universitaire de Nice (CHU), Cote d'Azur University, Nice, France.
[3]
Department of Hematology, Centre Hospitalier Le Mans, Le Mans, France.
[4]
Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Université de Toulouse 3 Paul Sabatier, Toulouse, France.
[5]
Hematology, Szpital Uniwersytecki nr 2, Dr Jana Biziela, Kujawsko-pomorskie, Bydgoszcz, Poland.;Department of Hematology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland.
[6]
Department of Hematology, University Hospital, Kraków, Poland.
[7]
Département Hématologie et Immunologie, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
[8]
Department of Hematology, CHU La Miletrie, Poitiers, France.
[9]
Service d'Hématologie Clinique, Hospices Civils de Lyon, Hôpital Lyon Sud, Lyon, France.
[10]
Haematology Department, S.C. Ematologia 2, Torino, Italy.
[11]
Department of Hematology and Transplantation, Medical University of Gdańsk, Gdańsk, Poland.
[12]
Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA.
[13]
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.
[14]
DOI
10.1080/10428194.2024.2431878
PMID
39606906
发布时间
2024-11-28
换一批
换一批
